Clinical information
Routine STD testing plays a critical role in preventive medicine, especially in pediatric medicine, family medicine, and public health. Screening helps detect sexually transmitted diseases (STDs) or sexually transmitted infections (STIs) early, often before symptoms appear. This proactive approach can significantly reduce long-term health complications and help prevent further transmission.
Key benefits include:
- Early identification of infections
- Timely treatment and reduced severity
- Protection of partners from sexual contact transmission
- Reduced healthcare burden due to untreated infectious and parasitic diseases
During an STD screening, if the results return positive, the provider must update the medical record with the relevant diagnostic examination code based on the disease detected.
Some of the most common STDs screened under this code include:
- Chlamydia – A common bacterial infection, especially in young adults
- Gonorrhea – Another bacterial infection often tested alongside chlamydia
- Syphilis – A potentially serious disease requiring early detection
- HIV (Human Immunodeficiency Virus) – Can be screened via antibody/antigen testing
- HPV (Human Papillomavirus) – Includes high-risk strains that may lead to cancer
- Hepatitis B – Often tested due to its link to sexual transmission
According to clinical guidelines and public health organizations, STD screening is especially recommended for:
- Sexually active individuals under 25
- Individuals with multiple partners
- People with known high-risk sexual behavior
- Men who have sex with men
- Patients in high-prevalence populations
Routine STI screening is essential in family medicine, pediatric medicine, and other specialties concerned with medical conditions linked to sexual contact.